Logo image of ART.DE

ARTNET AG - REG (ART.DE) Stock Fundamental Analysis

FRA:ART - Deutsche Boerse Ag - DE000A1K0375 - Common Stock - Currency: EUR

9.3  -0.2 (-2.11%)

Fundamental Rating

1

Overall ART gets a fundamental rating of 1 out of 10. We evaluated ART against 47 industry peers in the Specialty Retail industry. ART has a bad profitability rating. Also its financial health evaluation is rather negative. ART does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ART had negative earnings in the past year.
In the past year ART had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ART reported negative net income in multiple years.
Each year in the past 5 years ART had a positive operating cash flow.
ART.DE Yearly Net Income VS EBIT VS OCF VS FCFART.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M 2M

1.2 Ratios

Looking at the Return On Assets, with a value of -7.94%, ART is doing worse than 70.21% of the companies in the same industry.
ART has a worse Return On Equity (-27.51%) than 70.21% of its industry peers.
Industry RankSector Rank
ROA -7.94%
ROE -27.51%
ROIC N/A
ROA(3y)-4.83%
ROA(5y)0.64%
ROE(3y)-12.92%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ART.DE Yearly ROA, ROE, ROICART.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60 80

1.3 Margins

ART has a better Gross Margin (56.64%) than 85.11% of its industry peers.
ART's Gross Margin has declined in the last couple of years.
ART does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.64%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.93%
GM growth 5Y-1.58%
ART.DE Yearly Profit, Operating, Gross MarginsART.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

ART does not have a ROIC to compare to the WACC, probably because it is not profitable.
ART has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ART has more shares outstanding
Compared to 1 year ago, ART has an improved debt to assets ratio.
ART.DE Yearly Shares OutstandingART.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M 5M
ART.DE Yearly Total Debt VS Total AssetsART.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M

2.2 Solvency

ART has an Altman-Z score of -1.37. This is a bad value and indicates that ART is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.37, ART is doing worse than 70.21% of the companies in the same industry.
A Debt/Equity ratio of 0.01 indicates that ART is not too dependend on debt financing.
ART has a better Debt to Equity ratio (0.01) than 93.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -1.37
ROIC/WACCN/A
WACC7.31%
ART.DE Yearly LT Debt VS Equity VS FCFART.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2M 4M

2.3 Liquidity

ART has a Current Ratio of 0.37. This is a bad value and indicates that ART is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.37, ART is not doing good in the industry: 91.49% of the companies in the same industry are doing better.
A Quick Ratio of 0.37 indicates that ART may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.37, ART is doing worse than 78.72% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.37
Quick Ratio 0.37
ART.DE Yearly Current Assets VS Current LiabilitesART.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

ART shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -926.17%.
The Revenue has decreased by -6.71% in the past year.
Measured over the past years, ART shows a small growth in Revenue. The Revenue has been growing by 4.16% on average per year.
EPS 1Y (TTM)-926.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%138.46%
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y3.78%
Revenue growth 5Y4.16%
Sales Q2Q%-2.59%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ART.DE Yearly Revenue VS EstimatesART.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
ART.DE Yearly EPS VS EstimatesART.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 0 0.02 -0.02 -0.04 -0.06

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ART reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ART.DE Price Earnings VS Forward Price EarningsART.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

68.09% of the companies in the same industry are cheaper than ART, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 70.48
ART.DE Per share dataART.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ART!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ARTNET AG - REG

FRA:ART (4/25/2025, 7:00:00 PM)

9.3

-0.2 (-2.11%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)11-11 2024-11-11
Earnings (Next)05-07 2025-05-07
Inst Owners0.29%
Inst Owner ChangeN/A
Ins Owners37.87%
Ins Owner ChangeN/A
Market Cap53.10M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.27
P/FCF N/A
P/OCF 113.52
P/B 14.55
P/tB N/A
EV/EBITDA 70.48
EPS(TTM)-0.18
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)0.08
OCFY0.88%
SpS4.09
BVpS0.64
TBVpS-0.53
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.94%
ROE -27.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.64%
FCFM N/A
ROA(3y)-4.83%
ROA(5y)0.64%
ROE(3y)-12.92%
ROE(5y)0.22%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.93%
GM growth 5Y-1.58%
F-Score3
Asset Turnover1.85
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA 0.06
Cap/Depr 86.8%
Cap/Sales 6.99%
Interest Coverage N/A
Cash Conversion 59.01%
Profit Quality N/A
Current Ratio 0.37
Quick Ratio 0.37
Altman-Z -1.37
F-Score3
WACC7.31%
ROIC/WACCN/A
Cap/Depr(3y)93.08%
Cap/Depr(5y)87.53%
Cap/Sales(3y)6.1%
Cap/Sales(5y)5.88%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-926.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%138.46%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6.71%
Revenue growth 3Y3.78%
Revenue growth 5Y4.16%
Sales Q2Q%-2.59%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y33.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-188.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-81.11%
OCF growth 3Y-31.08%
OCF growth 5Y-3.16%